Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Michael Hofman

Peter MacCallum Cancer Institute

Australia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Jake Kendrick

Lecturer - Medical Applications of Artificial Intelligence

University of Western Australia

AUSTRALIA

View details

Ghulam Mubashar Hassan

University of Western Australia

AUSTRALIA

View details

Pejman Rowshanfarzad

University of Western Australia

AUSTRALIA

View details

Shankar Siva

University of Melbourne

AUSTRALIA

View details

Ashwin Parihar

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Arun Azad

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Belinda A. Campbell

department of medicine university of melbourne melbourne victoria australia

AUSTRALIA

View details

Paul M. Parizel

University of Western Australia

AUSTRALIA

View details

Declan Murphy

sir peter maccallum department of oncology university of melbourne melbourne victoria australia

AUSTRALIA

View details

Irene Virgolini

AUSTRIA

View details

Martin Ebert

University of Western Australia

AUSTRALIA

View details

JEREMIE CALAIS

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Gary Cook

King’s College London

UNITED KINGDOM

View details

Nirupa Sachithanandan

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Hofman

Research Interests

Make your next move.

Explore related searches

Articles (20)

Pre-therapeutic PSMA PET Imaging Biomarkers Demonstrate Prognostic Value in Patients Undergoing [177Lu]Lu-PSMA Therapy: A Systematic Review and Meta-analysis

The long and winding road of radiomics: learnings from two meta-analyses of the radiomics quality score

Guideline of guidelines: lutetium‐177 PSMA radioligand therapy in advanced prostate cancer

From salvage to spotlight: how 2025 transformed PSMA radioligand therapy

Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma

Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer

Success and Limitations of PSMA RLT : The Nuclear Medicine View

Peptide receptor radionuclide therapy in malignant insulinoma

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis

Shaping the future of 177Lu-PSMA-617 radiopharmaceutical therapy in prostate cancer: is earlier better, or is patient selection key?

Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer

Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer—a systematic review and meta-analysis

Combination Strategies and Targeted Radionuclide Therapies

Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate cancer

Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy

The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy

Role of FDG PET/CT in Management of Patients with Prostate Cancer

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)

177Lu–Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer

Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?

Collaborators (14)

Jake Kendrick

Ghulam Mubashar Hassan

Pejman Rowshanfarzad

Shankar Siva

Ashwin Parihar

Arun Azad

Belinda A. Campbell

Paul M. Parizel

Declan Murphy

Irene Virgolini

Martin Ebert

JEREMIE CALAIS

Gary Cook

Nirupa Sachithanandan

Make your next move.